Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines

Sabran, Affidah; Kumolosasi, Endang; Jantan, Ibrahim

doi:10.2478/acph-2019-0005

Abstract

Recent studies suggest that annexin A1 (ANXA1) promotes apoptosis in cancerous cells. This study aims to investigate the effects of ANXA1 on apoptosis and cell cycle arrest in K562, Jurkat and U937 cells and peripheral blood mononu-clear cells (PBMC). Cells were treated with ANXA1 and cyclophosphamide prior to flow cytometry analysis for apoptosis and cell cycle arrest induction. At 2.5µM, ANXA1 induced significant apoptosis in K562 (p ≤ 0.001) and U937 (p ≤ 0.05) cells, with EC₅₀ values of 3.6 and 3.8 µM, respectively. In Jurkat cells, induction was not significant (EC_50, 17.0 µM). No significant apoptosis induction was observed in PBMC. ANXA1 caused cycle arrest in the G0/G1 phase in K562 and U937 cells with p ≤ 0.001 for both, and (p ≤ 0.01) for Jurkat cells. ANXA1 induced apoptosis and cycle arrest in the G0/G1 phase in K562 and U937 cells, causing only cell cycle arrest in Jurkat cells.

References

1. W. J. Liu, T. Zhang, Q. L. Guo, C. Y. Liu and Y. Q. Bai, Effect of ATRA on the expression of HOXA5 gene in K562 cells and its relationship with cell cycle and apoptosis, Mol. Med. Rep. 13 (2016) 4221–4228; 10.3892/mmr.2016.508610.3892/mmr.2016.5086483814627052693
Search in Google Scholar Back to article
2. K. Yata, Y. Sadahira, T. Otsuki, H. Sakaguchi, Y. Isozaki and M. Uno, Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1, Br. J. Haematol.114 (2001) 591–599.10.1046/j.1365-2141.2001.02990.x11552984
Search in Google Scholar Back to article
3. B. T. Gjertsen and H. Wiig, Investigation of therapy resistance mechanisms in myeloid leukemia by protein profiling of bone marrow extracellular fluid, Expert Rev. Proteomics9 (2012) 595–598; https://doi.org/10.1586/epr.12.5510.1586/epr.12.5523256670
Search in Google Scholar Back to article
4. W. Ni, W. Qian and X. Tong, Cryptotanshinone induces apoptosis of HL-60 cells via mitochondrial pathway, Trop. J. Pharm. Res.13 (2014) 545–551.10.4314/tjpr.v13i4.9
Search in Google Scholar Back to article
5. S. Agrawal, M. Unterberg, S. Koschmieder, U. zur Stadt, U. Brunnberg, W. Verbeek, T. Büchner, W. E. Berdel, H. Serve and C. Müller-Tidow, DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia, Cancer Res. 67 (2007) 1370–1377; https://doi.org/10.1158/0008-5472.CAN-06-168110.1158/0008-5472.CAN-06-168117283175
Search in Google Scholar Back to article
6. Q. Y. Lu, Y. S. Jin, Z. F. Zhang, A. D. Le, D. Heber, F. P. Li, S. M. Dubinett and J. Y. Rao, Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annex-in-I in actin remodeling, Lab. Investig.87 (2007) 456–465; http://doi.org/10.1038/labinvest.370053410.1038/labinvest.370053417351649
Search in Google Scholar Back to article
7. S. H. Xia, L. P. Hu, H. Hu, W. T. Ying, X. Xu, Y. Cai, Y. L. Han, B. S. Chen, F. Wei, X. H. Qian, Y. Y. Cai, Y. Shen, M. Wu and M. R. Wang, Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas, Onco-gene21 (2002) 6641–664810.1038/sj.onc.120581812242662
Search in Google Scholar Back to article
8. R. Luthra, R. R. Singh, M. G. Luthra, Y. X. Li, C. Hannah, A. M. Romans, B. A. Barkoh, S. S. Chen, J. Enros, D. M. Maru, R. R. Boraddus, A. Rashid and C. T. Albarracin, MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers, Oncogene27 (2008) 6667–6678; https://doi.org/10.1038/onc.2008.25610.1038/onc.2008.25618663355
Search in Google Scholar Back to article
9. R. Duncan, B. Carpenter, L. C. Main, C. Telfer and G. I. Murray, Characterisation and protein expression profiling of annexins in colorectal cancer, Br. J. Cancer. 98 (2008) 426–433; https://doi.org/10.1038/sj.bjc.660412810.1038/sj.bjc.6604128236145018071363
Search in Google Scholar Back to article
10. R. Belvedere, V. Bizzarro, G. Forte, F. D. Piaz, L. Parente and A. Petrella, Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of formyl peptide receptor pathway, Sci. Reports6 (2016) 1–14.10.1038/srep29660
Search in Google Scholar Back to article
11. W. Ahmad, E. Kumolosasi, I. Jantan, M. Jasamai and E. Salim, Modulatory effect of phytoestrogens and curcumin on induction of annexin 1 in human peripheral blood mononuclear cells and their inhibitory effect on secretory phospholipase A₂, Trop. J. Pharm. Res.13 (2014) 171–177; https://doi.org/10.4314/tjpr.v13i2.110.4314/tjpr.v13i2.1
Search in Google Scholar Back to article
12. L. Parente and E. Solito, Annexin 1: More than an anti-phospholipase protein, Inflamm. Res. 53 (2004) 125–132; https://doi.org/10.1007/s00011-003-1235-z10.1007/s00011-003-1235-z
Search in Google Scholar Back to article
13. L. H. K. Lim and S. Pervaiz, Annexin 1 : the new face of an old molecule, FASEB J.24 (2007) 968–975; https://doi.org/10.1096/fj.06-7464rev10.1096/fj.06-7464rev
Search in Google Scholar Back to article
14. C. Guo, S. Liu and M-Z. Sun, Potential role of Anxa1 in cancer, Futur. Oncol. 9 (2013) 1773–1793; https://doi.org/10.2217/fon.13.11410.2217/fon.13.114
Search in Google Scholar Back to article
15. S. Canaider, E. Solito, C. de Coupade, R. J, Flower, F. Russo-Marie, N. J. Goulding and M. Peretti, Increased apoptosis in U937 cells over-expressing lipocortin 1 (Annexin I), Life Sci. 66 (2000) PL265-PL27010.1016/S0024-3205(00)00500-2
Search in Google Scholar Back to article
16. E. Solito E, C. De Coupade, S. Canaider, N. J. Goulding and M. Perretti, Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation, Br. J. Pharmacol. 13 (2001) 217–228; https://doi.org/10.1038/sj.bjp.070405410.1038/sj.bjp.0704054157277611350857
Search in Google Scholar Back to article
17. F. Hirata, Molecular targets, cancer chemoprevention, and dietary phytochemicals: Nuclear annexin A1 as a promising new molecular target of cancer chemoprevention, Austin J. Pharmacol. Ther.2 (2014) 2–3.
Search in Google Scholar Back to article
18. A. Petrella, C. W. D’Acunto, M. Rodriquez, M. Festa, A, Tosco, I. Bruno, S. Terracciano, M. Taddei, L. G. Paloma and L. Parente, Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: Role of annexin, Eur. J. Cancer.44 (2008) 740–749; https://doi.org/10.1016/j.ejca.2008.01.02310.1016/j.ejca.2008.01.02318295477
Search in Google Scholar Back to article
19. C. L. Rackham, A. E. Vargas, R. G. Hawkes, S. Amisten, S. J. Persaud, A. L. Austin, A. J. King and P. M. Jones, Annexin A1 is a key modulator of mesenchymal stromal cell-mediated improvements in islet function, Diabetes65 (2016) 129–139; https://doi.org/10.2337/db15-099010.2337/db15-099026470781
Search in Google Scholar Back to article
20. G. S. D. Purvis, F. Chiazza, J. Chen, R. Azevedo-Loiola, K. Martin, D. H. M. Kusters, C. C. Reutelingsperger, N. Fountoulakis, L. Gnudi, M. M. Yaqoob, M. Collino, C. Thiemermann and E. Solito, Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes, Diabetologia61 (2018) 482–495; https://doi.org/10.1007/s00125-017-4469-y10.1007/s00125-017-4469-y644895529085990
Search in Google Scholar Back to article
21. E. Cristante, S. McArthur, C. Mauro, E. Maggioli, I. A. Romero, M. Wylezinska-Arridge, P. O. Couraud, J. lopez-Tremoleda, H. C. Christian, B. B. Weksler, A. Malaspina and E. Solito, Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications, Proc. Natl. Acad. Sci. USA110 (2012) 832–841; https://doi.org/10.1073/pnas.120936211010.1073/pnas.1209362110354909423277546
Search in Google Scholar Back to article
22. M. Ries, R. Loiola, U. N. Shah, S. M. Gentleman, E. Solito and M. Sastre, The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide, J. Neuroinflammation (2016) 1–15; https://doi.org/10.1186/s12974-016-0692-610.1186/s12974-016-0692-6501075727590054
Search in Google Scholar Back to article
23. M. F. Maioral, P. C. Gaspar, G. R. Rosa Souza, A. Mascarello, L. D. Chiaradia, M. A. Licínio, A. C. Moraes, R. A. Yunes, R. J. Nunes and M. C. Santos-Silva, Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines, Biochimie95 (2013) 866–874; https://doi.org/10.1016/j.biochi.2012.12.00110.1016/j.biochi.2012.12.001
Search in Google Scholar Back to article
24. M. Luczak, M. Kaźmierczak, L. Handschuh, K. Lewandowski, M. Komarnicki and M. Figlerowicz, Comparative proteome analysis of acute myeloid leukemia with and without maturation, J. Proteomics75 (2012) 5734–5748; https://doi.org/10.1016/j.jprot.2012.07.03010.1016/j.jprot.2012.07.030
Search in Google Scholar Back to article
25. R. Debret, H. El Btaouri, L. Duca, I. Rahman, S. Radke, B. Haye, J. M. Sallenave and F. Antonicelli, Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells, FEBS Lett. 546 (2003) 195–202.10.1016/S0014-5793(03)00570-2
Search in Google Scholar Back to article
26. J. P. Vago, C. R. Nogueira, L. P. Tavares, F. M. Soriani, F. Lopes, R. C. Russo, V. Pinho, M. M. Teixeira and L. P. Sousa, Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis, J. Leukoc. Biol.92 (2012) 249–258; http://doi.org/10.1189/jlb.011200810.1189/jlb.0112008
Search in Google Scholar Back to article
27. G. Li, S. He, L. Chang, H. Lu, H. Zhang, H. Zhang and J. Chiu, GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol, Phytomedicine18 (2011) 704–709; https://doi.org/10.1016/j.phymed.2010.11.01510.1016/j.phymed.2010.11.015
Search in Google Scholar Back to article
28. R. N. Winter, A. Kramer, A. Borkowski and N. Kyprianou, Loss of caspase-1 and caspase-3 protein expression in human prostate cancer, Cancer Res. 61 (2001) 1227–1232.
Search in Google Scholar Back to article
29. T. C. Reddy, D. B. Reddy, A. Aparna, K. M. Arunasree, G. Gupta, C. Achari, G. V. Reddy, V. Lakshmipathi, A. Subramanyam and P. Reddanna, Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-ĸB inactivation, Toxicol. In Vitro26 (2012) 396–405; https://doi.org/10.1016/j.tiv.2011.12.01810.1016/j.tiv.2011.12.018
Search in Google Scholar Back to article
30. S. H. Ferreira, F. Q. Cunha, B. B. Lorenzetti, M. A. Michelin, M. Perretti, R. J. Flower and S. Poole, Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone, Br. J. Pharmacol. 121 (1997) 883–888; https://doi.org/10.1038/sj.bjp.070121110.1038/sj.bjp.0701211
Search in Google Scholar Back to article
31. Y. Nakanishi, R. Kamijo, K. Takizawa, M. Hatori and M. Nagumo, Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines, Eur. J. Cancer.37 (2001) 1570–1578.10.1016/S0959-8049(01)00160-5
Search in Google Scholar Back to article
32. A. M. Saleh, A. Aljada, M. M. El-Abadelah, M. O. Taha, S. S. Sabri, J. A. Zahra and M. A. Aziz, The anticancer activity of the substituted pyridone-annelated isoindigo (5’-Cl) involves G0/G1 cell cycle arrest and inactivation of CDKs in the promyelocytic leukemia cell line HL-60, Cell Physiol. Biochem.35 (2015) 1943–1957; https://doi.org/10.1159/00037400310.1159/00037400325870953
Search in Google Scholar Back to article
33. Y. Nagahara, Y. Matsuoka, K. Saito, M. Ikekita, S. Higuchi and T. Shinomiya, Coordinate involvement of cell cycle arrest and apoptosis strengthen the effect of FTY720, Jap. J. Cancer Res.92 (2001) 680–687.10.1111/j.1349-7006.2001.tb01148.x592676311429058
Search in Google Scholar Back to article
34. R. A. Weinberg, p53 and Apoptosis: Master Guardian and Executioner, in The Biology of Cancer (Ed. R. A. Weinberg), 2nd ed, Garland Science, New York 2014. pp. 331–390.
Search in Google Scholar Back to article

Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines

Abstract

Paradigm

My account